Onsior

1 x 20 ml
Liquid for injection, solution
SC

Active substance

  • Robenacoxib : 20 mg/ml
  • Species

    Cats and dogs.

    Indications

    For the treatment of pain and inflammation associated with orthopaedic or soft tissue surgery in dogs.

    For the treatment of pain and inflammation associated with orthopaedic or soft tissue surgery in cats.

    Dose to be administered and administration route

    Subcutaneous use.

    Administer subcutaneously to cats or dogs approximately 30 minutes before the start of surgery, for example around the time of induction of general anaesthesia, at a dose of 1 ml per 10 kg of body weight (2 mg/kg). After surgery in cats, once daily treatment may be continued at the same dosage and at the same time every day for up to 2 days. After soft tissue surgery in dogs, once daily treatment may be continued at the same dosage and at the same time every day for up to 2 days.

    The interchangeable use of Onsior tablets and Onsior solution for injection has been tested in target animal safety studies and was shown to be well tolerated by cats and dogs.

    Onsior solution for injection or tablets may be used interchangeably in accordance with the indications and directions of use approved for each pharmaceutical form. Treatment should not exceed one dose (either tablet or injection) per day. Please note that the recommended doses for the two formulations may be different.

    Adverse reactions

    Cats:

    Common

    (1 to 10 animals / 100 animals treated):

    Injection site pain

    Digestive tract disorder1, Diarrhoea1, Vomiting1

    Uncommon

    (1 to 10 animals / 1000 animals treated):

    Bloody diarrhoea, Blood in vomit

    1Most cases were mild and recovered without treatment.

    Dogs:

    Common

    (1 to 10 animals / 100 animals treated):

    Injection site pain1

    Digestive tract disorder2, Diarrhoea2, Vomiting2

    Uncommon

    (1 to 10 animals / 1000 animals treated):

    Tarry stool

    Decreased appetite

    1 Moderate or severe pain at injection site was uncommon

    2 Most cases were mild and recovered without treatment.

    Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for contact details.

    References

    Leaflet is unavailable
    Cat
    Dog
    PRICE Only for registered vets. Create a free profile to access all features.. Login
    Art. Nr. 52127/5021
    EAN 5037694024185
    PACKAGES
    Onsior
    Elanco Animal Health
    1 x 20 ml
    52127/5021
    VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
    VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.